31 October 2017

Interrad Medical, Inc.

LGB is acting as the European placement agent in the $7 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com). 

The company has developed a platform technology for the stabilisation of catheters using a sub-cutaneous anchor. The UK's NICE issued guidance in favour of the use of its lead product, SecurAcath, in June. More than $5 million of notes have been issued so far. 

Recent Articles

26 May 2020

BoE: Negative interest rates not ruled out

Andrew Boyle, CEO of LGB & Co. Limited, contributed to an article for Mortgage Introducer Bank of England Governor Andrew Bailey's refusal to rule out the prospect of negative interest rates.

 

Read more

News & Insights

4 May 2020

Small cap movers: Coronavirus crisis shines a light on small-cap pharma

Ivan Sedgwick, Investments Director at LGB & Co. Limited, contributed to an article for ProActive Investors on small-cap pharmaceutical companies in the Coronavirus limelight.

Read more

News & Insights

30 April 2020

What impact is COVID-19 having on stocks?

Ivan Sedgwick, Director of Investments at LGB & Co, spoke to BLM to find out about the current outlook for the AIM market.

 

Read more

News & Insights